About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Oncology
›
top-articles
Current Oncology
2.3
(top 20%)
impact factor
4.0K
(top 5%)
papers
38.8K
(top 10%)
citations
71
(top 10%)
h
-index
2.4
(top 20%)
extended IF
4.2K
all documents
42.6K
doc citations
106
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Current Oncology
2020
554
2
Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy
Current Oncology
2011
301
3
Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the Literature
Current Oncology
2010
276
4
Advances in the Systemic Treatment of Triple-Negative Breast Cancer
Current Oncology
2018
241
5
Immune Checkpoint Inhibitors in Cancer Therapy
Current Oncology
2022
239
6
Nonsurgical Treatment of Recurrent Glioblastoma
Current Oncology
2015
228
7
Microrna Let-7: An Emerging Next-Generation Cancer Therapeutic
Current Oncology
2010
226
8
Mindfulness-Based Stress Reduction for Breast Cancer—A Systematic Review and Meta-Analysis
Current Oncology
2012
205
9
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Current Oncology
2007
201
10
Development of Cell-Cycle Inhibitors for Cancer Therapy
Current Oncology
2009
201
11
A Review of the Reliability and Validity of the Edmonton Symptom Assessment System
Current Oncology
2009
198
12
Anticancer Mechanisms of Cannabinoids
Current Oncology
2016
192
13
Exercise for People with Cancer: A Clinical Practice Guideline
Current Oncology
2017
189
14
Symptom Clusters in Cancer Patients: A Review of the Literature
Current Oncology
2007
188
15
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1
Current Oncology
2006
182
16
Current Management of Castrate-Resistant Prostate Cancer
Current Oncology
2010
180
17
Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain Metastases
Current Oncology
2013
171
18
Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic Review
Current Oncology
2007
153
19
Screening for Breast Cancer in 2018—What Should We be Doing Today?
Current Oncology
2018
152
20
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
Current Oncology
2009
139
21
Information Needs and Sources of Information for Patients during Cancer Follow-Up
Current Oncology
2014
138
22
How Effective Is Video Consultation in Clinical Oncology? A Systematic Review
Current Oncology
2010
137
23
Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1
Current Oncology
2006
135
24
Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group
Current Oncology
2008
127
25
The Colon Health and Life-Long Exercise Change (CHALLENGE) trial (CO.21)
Current Oncology
2008
124
26
Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea
Current Oncology
2007
124
27
Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations
Current Oncology
2009
120
28
Complementary and Alternative Medicine Use in Patients Before and After a Cancer Diagnosis
Current Oncology
2018
118
29
Managing Treatment-Related Adverse Events Associated with egfr Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
Current Oncology
2011
116
30
Two Cases of Acrometastasis to the Hands and Review of the Literature
Current Oncology
2008
115
31
Treatment Paradigms for Patients with Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line
Current Oncology
2012
114
32
A Pan-Canadian Practice Guideline and Algorithm: Screening, Assessment, and Supportive Care of Adults with Cancer-Related Fatigue
Current Oncology
2013
112
33
Use of Dexamethasone in Patients with High-Grade Glioma: A Clinical Practice Guideline
Current Oncology
2014
112
34
Fine-Needle Sspiration Biopsy versus Core-Needle Biopsy in Diagnosing Lung Cancer: A Systematic Review
Current Oncology
2012
110
35
Current Landscape of Immunotherapy in the Treatment of Solid Tumours, with Future Opportunities and Challenges
Current Oncology
2018
109
36
A New Standard of Care for the Management of Peritoneal Surface Malignancy
Current Oncology
2011
108
37
Has the Practice of Radiation Oncology for Locally Advanced and Metastatic Non-Small-Cell Lung Cancer Changed in Canada?
Current Oncology
2010
107
38
Management of Single Brain Metastasis: A Practice Guideline
Current Oncology
2007
104
39
Connecting People with Cancer to Physical Activity and Exercise Programs: A Pathway to Create Accessibility and Engagement
Current Oncology
2018
103
40
Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge
Current Oncology
2013
102
41
Pheochromocytoma and paraganglioma syndromes: genetics and management update
Current Oncology
2014
102
42
Exercise for People with Cancer: A Systematic Review
Current Oncology
2017
100
43
Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Brief Review
Current Oncology
2018
98
44
Canadian Recommendations for the Treatment of Glioblastoma Multiforme
Current Oncology
2007
98
45
High-Grade Hyperinvasive Sarcomatoid Urothelial Bladder Carcinoma Demonstrating Complete Response to Bladder-Preserving Chemoradiation
Current Oncology
2009
98
46
Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer
Current Oncology
2010
97
47
Overcoming Endocrine Resistance in Hormone Receptor–Positive Breast Cancer
Current Oncology
2018
96
48
Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer
Current Oncology
2015
95
49
Integrating Cannabis into Clinical Cancer Care
Current Oncology
2016
95
50
Denosumab and Giant Cell Tumour of Bone—A Review and Future Management Considerations
Current Oncology
2013
94
site/software ©
exaly
; All materials licenced under
CC by-SA
.